Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2009
11/05/2009WO2009111218A3 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same
11/05/2009WO2009109869A3 Alcohol antimicrobial skin sanitizing compositions including cationic compatible thickeners
11/05/2009WO2009106991A3 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders
11/05/2009WO2009105164A3 Blood substitute solution
11/05/2009WO2009104932A3 Composite preparation
11/05/2009WO2009104916A3 Pharmaceutical formulations for the treatment of cardiovascular diseases
11/05/2009WO2009100107A3 Alendronate formulations, method of making and method of use thereof
11/05/2009WO2009098520A3 Composition and method for assisting swallowing
11/05/2009WO2009084069A4 Ocular solution with organic lycopene
11/05/2009WO2009077693A3 Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent
11/05/2009WO2009064814A3 Tri-molecular complexes and their use in drug delivery systems
11/05/2009WO2009061909A3 Wet granulation using a water sequestering agent
11/05/2009WO2009054841A3 Heat stable microcapsules and methods for making and using the same
11/05/2009WO2009002829A3 Tableted compositions containing atazanavir
11/05/2009WO2009002826A3 Tableted compositions containing atazanavir
11/05/2009WO2009002823A3 Tableted compositions containing atazanavir
11/05/2009WO2009002821A3 Tableted compositions containing atazanavir
11/05/2009WO2008148080A3 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin]
11/05/2009WO2006078979A4 Vectors and methods for genetic immunization
11/05/2009US20090275923 Electronic capsule for treating gastrointestinal disease
11/05/2009US20090275877 Method of Enhancing Electrotransport Polypeptide Flux By Amino Acid Substitution with Histidine
11/05/2009US20090275645 Method to induce neovascular formation and tissue regeneration
11/05/2009US20090275545 Medicinal targeted local lipolysis
11/05/2009US20090275531 Method for producing starch networks and initial products
11/05/2009US20090274766 Compositions and Methods For Inhibiting Gastric Acide Secretion Using Derivatives of Small Dicarboxylic Acids in Combination with PPI
11/05/2009US20090274765 Compositions and Methods for Drug Delivery
11/05/2009US20090274764 Hollow Foam Beads for Treatment of Glioblastoma
11/05/2009US20090274763 Immunoadjuvant
11/05/2009US20090274762 Rehydratable pharmaceutical product
11/05/2009US20090274761 Transdermal delivery of (r)-3,3-diphenylpropylamin-monoestern
11/05/2009US20090274760 Use of An Alkyl Glycoside Or Of A Mixture Of Alkyl Glycosides Having Anti-Ageing And/Or Calming Properties As Active Agents In Cosmetic Compositions, And Methods Of Cosmetic Care Using Said Compositions
11/05/2009US20090274759 Solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids
11/05/2009US20090274758 Solid Composition for Intra-Oral Delivery of Insulin
11/05/2009US20090274757 Pharmaceutical polish formulations
11/05/2009US20090274756 Stabilized composition
11/05/2009US20090274755 Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
11/05/2009US20090274754 Dual action, inhaled formulations providing both an immediate and sustained release profile
11/05/2009US20090274753 Ph-sensitive polymeric micelles for drug delivery
11/05/2009US20090274751 Growth Factor Sensitive Vesicle
11/05/2009US20090274750 Therapeutic Treatment of Dermatologic Skin Disorders
11/05/2009US20090274749 Topical Application for Minimizing Melanin Production
11/05/2009US20090274748 Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous absorption, and process for producing the same
11/05/2009US20090274747 Pressure-Sensitive Adhesive Base and Medical Adhesive Patch Including the Pressure-Sensitive Adhesive Base
11/05/2009US20090274746 Methods and compositions for controlled delivery of phytochemical agents
11/05/2009US20090274745 Drug delivery systems based on catonic siloxanyl macromonomers
11/05/2009US20090274744 Drug delivery system based on cationic siloxanyl macromonomers
11/05/2009US20090274740 Drug-loaded medical devices and methods for manufacturing drug-loaded medical devices
11/05/2009US20090274737 Implant comprising a surface of reduced thrombogenicity
11/05/2009US20090274734 Method for obtaining hollow particles
11/05/2009US20090274733 Pharmaceutical preparation containing copolyvidone
11/05/2009US20090274732 Type-2 Diabetes Combination Wafer
11/05/2009US20090274731 Production of enveloped pharmaceutical dosage forms
11/05/2009US20090274730 Compositions and methods for treating inflammation
11/05/2009US20090274654 Methods and devices for the sustained release of multiple drugs
11/05/2009US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/05/2009US20090274631 RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions
11/05/2009CA2723215A1 Compositions and methods for treating digestive disorders
11/05/2009CA2723117A1 Versatile disinfectant
11/05/2009CA2723053A1 Continuous process for making pharmaceutical compositions
11/05/2009CA2722743A1 Novel formulations for treatment of migraine
11/05/2009CA2722658A1 Compositions and methods for treating multiple sclerosis
11/05/2009CA2722491A1 Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide
11/05/2009CA2722408A1 Lipid composition
11/05/2009CA2722121A1 A homeopathic formulation
11/05/2009CA2722050A1 Polymerized micelles
11/05/2009CA2722002A1 Composite lacrimal insert and related methods
11/05/2009CA2721485A1 Ordered mesoporous silica material
11/05/2009CA2720856A1 The use of solid carrier particles to improve the processability of a pharmaceutical agent
11/04/2009EP2113315A2 Disposal system for transdermal dosage form
11/04/2009EP2113252A1 A forsythoside injection and preparation thereof
11/04/2009EP2113250A1 Patch package structure
11/04/2009EP2113249A1 Antimycotic patch
11/04/2009EP2113248A1 Pharmaceutical composition comprising N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2-,4-dimethyl-1H-pyrrole-3-carboxamide
11/04/2009EP2113247A2 High efficiency encapsulation of nucleic acids in lipid vesicles
11/04/2009EP2113246A1 Compositions for delivery of therapeutics into the eyes and methods for making and using the same
11/04/2009EP2113230A2 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
11/04/2009EP2112931A1 Methods and compositions for transermal delivery of nucleotides
11/04/2009EP2112925A2 Solid pharmaceutical dosage formulations
11/04/2009EP2112924A1 Delta 9 - tetrahydrocannabinol processing
11/04/2009EP2112923A1 Intranasal, buccal, and sublingual administration of metanicotine analogs
11/04/2009EP2112922A2 A polyamide rate-modulated monolithic drug delivery system
11/04/2009EP2112921A1 A controlled release composition
11/04/2009EP2112920A1 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
11/04/2009EP1773296B1 Pharmaceutical vaginal gel comprising tenofovir
11/04/2009EP1658129B1 Static micromixer
11/04/2009EP1658128B1 Multi-constituent packaging comprising a static micromixer and method for producing formulations
11/04/2009EP1490121B1 Drug delivery particle
11/04/2009EP1480736B1 Microcapsules having high carotenoid content
11/04/2009EP1471151B1 Improved method of production of lycopene by the fermentation of selected strains of blakeslea trispora.
11/04/2009EP1420645B1 Multivesicular emulsion topical delivery systems
11/04/2009EP1140039B1 Transparent transdermal nicotine delivery devices
11/04/2009EP1011695B2 Use of neurotoxin therapy for treatment of prostate disorders
11/04/2009EP0879236B1 Derivatives of camptothecin for use in treating cancer
11/04/2009CN101573111A Formulations of phospholipase enzyme inhibitors
11/04/2009CN101569612A Lyophilized clindamycin phosphate powder needle reagent
11/03/2009US7612176 Polymer-based sustained release device
11/03/2009US7612168 Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV
11/03/2009US7612116 Use of thickening agents for producing soft capsules and film production method
11/03/2009US7612115 Citric acid, polyethylene glycol, and ofloxacin; low gelation temperatures; bioavailability
11/03/2009US7612112 Extended release oral drug dosage form of gabapentin surrounded by a semipermeable membrane; epilepsy, neuropathic pain, psychological disorders, movement disorders, prophylaxis of migraines
1 ... 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 ... 2991